# Executive Strategy Summary Implementation Plan

> **For agentic workers:** REQUIRED SUB-SKILL: Use superpowers:subagent-driven-development (recommended) or superpowers:executing-plans to implement this plan task-by-task. Steps use checkbox (`- [ ]`) syntax for tracking.

**Goal:** Generate a polished executive strategy summary synthesizing all Verdana planning data into a strategic recommendation, output as both a styled HTML scrolling narrative and a markdown document.

**Architecture:** Two static files with identical content — a self-contained HTML file with embedded CSS (no JavaScript) and a clean markdown file. Content is baked in from analysis of the brand definition, scenario modeler, market sizing, OKR planner, and competitive positioning tools.

**Tech Stack:** HTML/CSS (no JS), Markdown

**Spec:** `docs/superpowers/specs/2026-04-06-executive-strategy-summary-design.md`

**Outputs:**
- `tools/executive_strategy_summary.html`
- `output/executive_strategy_summary.md`

---

## Task 1: Create the HTML Executive Strategy Summary

**Files:**
- Create: `tools/executive_strategy_summary.html`

This task creates the complete styled HTML scrolling narrative with all 6 sections.

- [ ] **Step 1: Create the HTML file**

Create `tools/executive_strategy_summary.html`:

```html
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Verdana — Executive Strategy Summary FY2027</title>
<style>
*, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }
body {
  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
  background: #f8faf7;
  color: #333;
  line-height: 1.6;
}
.page {
  max-width: 800px;
  margin: 0 auto;
  background: #fff;
  min-height: 100vh;
  box-shadow: 0 0 30px rgba(0,0,0,0.06);
}

/* Hero Header */
.hero {
  background: #2d6a4f;
  color: #fff;
  padding: 48px 40px;
  text-align: center;
}
.hero-eyebrow {
  font-size: 11px;
  text-transform: uppercase;
  letter-spacing: 3px;
  opacity: 0.7;
  margin-bottom: 8px;
}
.hero h1 {
  font-size: 28px;
  font-weight: 700;
  letter-spacing: -0.5px;
  margin-bottom: 6px;
}
.hero-date {
  font-size: 12px;
  opacity: 0.6;
}

/* Sections */
.section {
  padding: 32px 40px;
  border-bottom: 1px solid #eee;
}
.section:last-child { border-bottom: none; }
.section-header {
  display: flex;
  align-items: center;
  gap: 10px;
  margin-bottom: 16px;
}
.section-number {
  width: 28px;
  height: 28px;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-size: 13px;
  font-weight: 700;
  color: #fff;
  flex-shrink: 0;
}
.section-number.green { background: #2d6a4f; }
.section-number.red { background: #c0392b; }
.section-number.purple { background: #6b4c9a; }
.section-title {
  font-size: 18px;
  font-weight: 700;
}
.section-title.green { color: #2d6a4f; }
.section-title.red { color: #c0392b; }
.section-title.purple { color: #6b4c9a; }

/* Narrative text */
.narrative {
  font-size: 14px;
  color: #444;
  line-height: 1.7;
  margin-bottom: 16px;
}

/* KPI cards */
.kpi-row {
  display: flex;
  gap: 10px;
  margin-top: 16px;
}
.kpi-card {
  flex: 1;
  background: #fff;
  border: 1px solid #e8e8e8;
  border-radius: 8px;
  padding: 12px;
  text-align: center;
}
.kpi-label {
  font-size: 11px;
  color: #888;
  margin-bottom: 4px;
}
.kpi-value {
  font-size: 22px;
  font-weight: 700;
}
.kpi-value.green { color: #2d6a4f; }
.kpi-value.red { color: #c0392b; }
.kpi-value.neutral { color: #333; }

/* Recommendation callout */
.recommendation {
  background: #f0faf0;
  border-left: 4px solid #2d6a4f;
  border-radius: 0 8px 8px 0;
  padding: 16px 20px;
  margin-bottom: 20px;
}
.recommendation h3 {
  font-size: 16px;
  font-weight: 700;
  color: #2d6a4f;
  margin-bottom: 6px;
}
.recommendation p {
  font-size: 14px;
  color: #444;
  line-height: 1.6;
}

/* Rationale cards */
.rationale-row {
  display: flex;
  gap: 10px;
  margin-bottom: 20px;
}
.rationale-card {
  flex: 1;
  background: #f8faf7;
  border-radius: 8px;
  padding: 14px;
}
.rationale-card h4 {
  font-size: 13px;
  font-weight: 700;
  color: #2d6a4f;
  margin-bottom: 4px;
}
.rationale-card p {
  font-size: 12px;
  color: #555;
  line-height: 1.5;
}

/* Evidence section */
.evidence-label {
  font-size: 12px;
  font-weight: 700;
  color: #888;
  text-transform: uppercase;
  letter-spacing: 0.5px;
  margin-bottom: 10px;
}
.evidence-item {
  margin-bottom: 12px;
}
.evidence-item h4 {
  font-size: 13px;
  font-weight: 600;
  color: #2d6a4f;
  margin-bottom: 2px;
}
.evidence-item p {
  font-size: 13px;
  color: #555;
  line-height: 1.6;
}

/* Projection table */
.projection-table {
  width: 100%;
  border-collapse: collapse;
  font-size: 13px;
  margin-bottom: 16px;
}
.projection-table th {
  text-align: center;
  padding: 8px 12px;
  border-bottom: 2px solid #2d6a4f;
  font-weight: 600;
}
.projection-table th:first-child {
  text-align: left;
  color: #888;
  font-weight: 400;
}
.projection-table th.recommended {
  color: #2d6a4f;
  background: #f0faf0;
}
.projection-table th.baseline {
  color: #888;
  font-weight: 400;
}
.projection-table td {
  text-align: center;
  padding: 8px 12px;
  border-bottom: 1px solid #eee;
}
.projection-table td:first-child {
  text-align: left;
  color: #555;
}
.projection-table td.recommended {
  background: #f0faf0;
  font-weight: 600;
}
.projection-table .delta-positive { color: #2d6a4f; }
.projection-table .delta-negative { color: #c17817; }

.net-impact {
  background: #f8faf7;
  border-radius: 8px;
  padding: 12px 16px;
  font-size: 13px;
  color: #444;
  line-height: 1.6;
}
.net-impact strong { color: #2d6a4f; }

/* Risk rows */
.risk-row {
  background: #fff5f5;
  border-radius: 8px;
  padding: 12px 16px;
  margin-bottom: 8px;
  display: flex;
  gap: 16px;
  align-items: baseline;
}
.risk-name {
  font-size: 13px;
  font-weight: 700;
  color: #c0392b;
  white-space: nowrap;
  min-width: 130px;
}
.risk-desc {
  font-size: 13px;
  color: #555;
  flex: 1;
}
.risk-mitigate {
  font-size: 12px;
  color: #2d6a4f;
  font-style: italic;
  min-width: 200px;
}

/* Contingency cards */
.contingency-row {
  display: flex;
  gap: 12px;
}
.contingency-card {
  flex: 1;
  border: 1px solid #ddd;
  border-radius: 10px;
  padding: 16px;
}
.contingency-card h4 {
  font-size: 14px;
  font-weight: 700;
  color: #6b4c9a;
  margin-bottom: 6px;
}
.contingency-card p {
  font-size: 12px;
  color: #555;
  line-height: 1.5;
  margin-bottom: 6px;
}
.contingency-trigger {
  font-size: 12px;
  color: #c17817;
  font-style: italic;
}

/* Next steps */
.step-item {
  display: flex;
  gap: 10px;
  align-items: flex-start;
  padding: 8px 10px;
  background: #f8faf7;
  border-radius: 6px;
  margin-bottom: 6px;
}
.step-checkbox {
  width: 18px;
  height: 18px;
  border: 2px solid #2d6a4f;
  border-radius: 4px;
  flex-shrink: 0;
  margin-top: 1px;
}
.step-text {
  font-size: 13px;
  color: #444;
}
.step-owner {
  font-size: 11px;
  color: #888;
  font-style: italic;
}

/* Print */
@media print {
  body { background: #fff; }
  .page { box-shadow: none; max-width: 100%; }
  .hero { padding: 24px; }
}
</style>
</head>
<body>
<div class="page">

  <!-- HERO -->
  <div class="hero">
    <div class="hero-eyebrow">Verdana FY2027 Strategic Plan</div>
    <h1>Executive Strategy Summary</h1>
    <div class="hero-date">Prepared April 2026 &middot; Confidential</div>
  </div>

  <!-- SECTION 1: EXECUTIVE OVERVIEW -->
  <div class="section">
    <div class="section-header">
      <div class="section-number green">1</div>
      <div class="section-title green">Executive Overview</div>
    </div>
    <p class="narrative">
      Verdana is an $8M annual revenue direct-to-consumer adaptogen supplement company with 60 employees. Built on a foundation of clinical transparency &mdash; publishing dosages, sourcing, and third-party test results that most brands hide &mdash; Verdana has earned the trust of health-conscious professionals who are skeptical of wellness hype.
    </p>
    <p class="narrative">
      However, the company has hit a growth plateau. Revenue has been flat for two consecutive quarters. Customer acquisition cost has risen 41% year-over-year to $58, driven by increasing Meta CPMs, iOS privacy changes, and podcast ad saturation. Monthly new customers have declined from 1,800 to 1,400 over the past six months, and the LTV:CAC ratio has dropped from 5.2:1 to 3.8:1.
    </p>
    <p class="narrative">
      The leadership team faces three interconnected strategic decisions: whether to expand into wholesale retail (Whole Foods and Target have both expressed interest), how to handle the underperforming Shield SKU (volume down 18% YoY, highest return rate), and whether to launch new products from the R&D pipeline (Metabolize and Glow). The company cannot pursue all options simultaneously &mdash; this document recommends a path and projects its impact.
    </p>
    <div class="kpi-row">
      <div class="kpi-card">
        <div class="kpi-label">Current Revenue</div>
        <div class="kpi-value green">$8.0M</div>
      </div>
      <div class="kpi-card">
        <div class="kpi-label">Gross Margin</div>
        <div class="kpi-value green">76.4%</div>
      </div>
      <div class="kpi-card">
        <div class="kpi-label">CAC</div>
        <div class="kpi-value red">$58 &#9650;41%</div>
      </div>
      <div class="kpi-card">
        <div class="kpi-label">Team</div>
        <div class="kpi-value neutral">60</div>
      </div>
    </div>
  </div>

  <!-- SECTION 2: RECOMMENDATION -->
  <div class="section">
    <div class="section-header">
      <div class="section-number green">2</div>
      <div class="section-title green">Recommended Strategic Direction</div>
    </div>
    <div class="recommendation">
      <h3>Selective Expansion: Wholesale + Cut Shield</h3>
      <p>
        Enter Whole Foods regional (85 stores, Pacific Northwest and Northern California) while discontinuing the underperforming Shield SKU. Reallocate Shield resources &mdash; 60% to marketing for CAC reduction, 40% to margin improvement. Hold new product launches (Metabolize, Glow) for Year 2, contingent on wholesale success.
      </p>
    </div>

    <div class="rationale-row">
      <div class="rationale-card">
        <h4>Revenue Unlock</h4>
        <p>Wholesale adds $2.1M in Year 3 revenue while DTC optimization continues to compound. Two growth engines instead of one.</p>
      </div>
      <div class="rationale-card">
        <h4>Margin Defense</h4>
        <p>Cutting Shield reclaims 1.2% blended margin, partially offsetting wholesale margin drag. Net gross profit increases despite lower margin rate.</p>
      </div>
      <div class="rationale-card">
        <h4>Manageable Risk</h4>
        <p>Two strategic moves, not three. Keeps execution bandwidth focused for a 60-person team. Medium risk profile with clear contingencies.</p>
      </div>
    </div>

    <div class="evidence-label">Supporting Evidence from Planning Analysis</div>

    <div class="evidence-item">
      <h4>Scenario Modeler</h4>
      <p>The Wholesale + Cut Shield combination projects $12.4M Year 3 revenue versus $9.8M baseline &mdash; a $2.6M uplift. Adding new products would push to a high-risk profile for only $2.2M additional upside, an unfavorable risk-to-reward ratio for a company of Verdana&rsquo;s scale.</p>
    </div>
    <div class="evidence-item">
      <h4>Market Sizing</h4>
      <p>Whole Foods at 85 stores with 24 units per store per month at 50% wholesale discount yields meaningful revenue with a manageable 6-month ramp. Target national is deferred until Whole Foods proves the retail model. DTC cannibalization is modeled conservatively at 10%.</p>
    </div>
    <div class="evidence-item">
      <h4>OKR Alignment</h4>
      <p>This path maps directly to the Base Case OKR framework: reduce CAC from $58 to $45, grow subscription rate from 34% to 40%, and rationalize the product portfolio. Shield discontinuation frees R&D and marketing bandwidth for the objectives that matter most.</p>
    </div>
    <div class="evidence-item">
      <h4>Competitive Positioning</h4>
      <p>Verdana&rsquo;s transparency score (95/100) is its strongest moat. Whole Foods&rsquo; premium health aisle reinforces clinical positioning rather than diluting it &mdash; unlike Target, which carries brand dilution risk. The closest competitive threat is Ritual (85/100 transparency, $100M+ scale). Establishing retail presence now builds a distribution advantage before Ritual potentially enters adaptogens.</p>
    </div>
  </div>

  <!-- SECTION 3: FINANCIAL PROJECTIONS -->
  <div class="section">
    <div class="section-header">
      <div class="section-number green">3</div>
      <div class="section-title green">3-Year Financial Projections</div>
    </div>
    <table class="projection-table">
      <thead>
        <tr>
          <th>Metric</th>
          <th class="baseline">Baseline<br>(Stay the Course)</th>
          <th class="recommended">Recommended<br>(WS + Cut Shield)</th>
          <th>Delta</th>
        </tr>
      </thead>
      <tbody>
        <tr><td>Y1 Revenue</td><td>$8.4M</td><td class="recommended">$9.1M</td><td class="delta-positive">+$700K</td></tr>
        <tr><td>Y2 Revenue</td><td>$9.1M</td><td class="recommended">$10.8M</td><td class="delta-positive">+$1.7M</td></tr>
        <tr><td>Y3 Revenue</td><td>$9.8M</td><td class="recommended">$12.4M</td><td class="delta-positive">+$2.6M</td></tr>
        <tr><td>Y3 Gross Margin</td><td>76.4%</td><td class="recommended">68.2%</td><td class="delta-negative">-8.2%</td></tr>
        <tr><td>Y3 Gross Profit</td><td>$7.5M</td><td class="recommended">$8.5M</td><td class="delta-positive">+$1.0M</td></tr>
        <tr><td>3Y Cumulative Investment</td><td>$0</td><td class="recommended">$420K</td><td class="delta-negative">+$420K</td></tr>
        <tr><td>Y3 Headcount</td><td>60</td><td class="recommended">64</td><td>+4</td></tr>
      </tbody>
    </table>
    <div class="net-impact">
      <strong>Net impact:</strong> $2.6M additional Year 3 revenue at the cost of 8.2% margin compression and $420K cumulative investment. Year 3 gross profit reaches $8.5M under the recommended path versus $7.5M at baseline &mdash; a $1.0M improvement in absolute profit despite the lower margin rate. The investment pays back within Year 1 wholesale revenue.
    </div>
  </div>

  <!-- SECTION 4: RISKS -->
  <div class="section">
    <div class="section-header">
      <div class="section-number red">4</div>
      <div class="section-title red">Key Risks &amp; Mitigations</div>
    </div>
    <div class="risk-row">
      <div class="risk-name">Brand Dilution</div>
      <div class="risk-desc">Retail shelf presence may undermine premium DTC positioning and the clinical trust Verdana has built.</div>
      <div class="risk-mitigate">Start regional (Whole Foods only), monitor brand sentiment quarterly, maintain premium in-store presentation.</div>
    </div>
    <div class="risk-row">
      <div class="risk-name">Margin Compression</div>
      <div class="risk-desc">Wholesale at ~38% gross versus 76% DTC drags the blended margin by 8.2 percentage points.</div>
      <div class="risk-mitigate">Track gross profit dollars, not margin %. Shield savings offset ~1.2%. Negotiate toward 45% discount at volume.</div>
    </div>
    <div class="risk-row">
      <div class="risk-name">Ops Complexity</div>
      <div class="risk-desc">EDI integration, retail compliance, and chargeback management are entirely new capabilities for the team.</div>
      <div class="risk-mitigate">Hire wholesale ops team before launch. Budget $150K for systems buildout. 6-month ramp protects against early stumbles.</div>
    </div>
    <div class="risk-row">
      <div class="risk-name">DTC Cannibalization</div>
      <div class="risk-desc">Some existing DTC customers may shift to retail purchases at lower margin, reducing per-customer profitability.</div>
      <div class="risk-mitigate">Model 10% cannibalization (conservative). Monitor DTC metrics weekly post-launch. Geographic overlap analysis.</div>
    </div>
    <div class="risk-row">
      <div class="risk-name">Customer Disruption</div>
      <div class="risk-desc">Shield subscribers need a migration path. Some will churn entirely rather than switch products.</div>
      <div class="risk-mitigate">Proactive communication plan. Offer Focus or Calm as replacement with transition discount. Target &lt; 5% subscriber loss.</div>
    </div>
  </div>

  <!-- SECTION 5: CONTINGENCIES -->
  <div class="section">
    <div class="section-header">
      <div class="section-number purple">5</div>
      <div class="section-title purple">What If We&rsquo;re Wrong? Contingency Paths</div>
    </div>
    <div class="contingency-row">
      <div class="contingency-card">
        <h4>Path B &mdash; Escalate (All Three Moves)</h4>
        <p>If wholesale exceeds expectations, add the Metabolize launch to the plan. This raises the Year 3 ceiling to $14.6M but pushes to a high-risk profile with $720K investment and +7 headcount.</p>
        <p>The logic: prove wholesale ops capability first, then layer on product launch complexity from a position of strength.</p>
        <div class="contingency-trigger">Trigger: Wholesale gross margin &gt; 42% by Q2 Year 1</div>
      </div>
      <div class="contingency-card">
        <h4>Path C &mdash; Retreat (DTC Only)</h4>
        <p>If wholesale underperforms, pause the expansion and redirect investment into DTC optimization, subscription growth, and loyalty program development. Year 3 floor: $9.8M revenue, low risk.</p>
        <p>This is not failure &mdash; it&rsquo;s the original business model, optimized. The DTC channel still has room to grow through CAC reduction and retention improvement.</p>
        <div class="contingency-trigger">Trigger: Wholesale revenue &lt; 30% of projection by Q2 Year 1</div>
      </div>
    </div>
  </div>

  <!-- SECTION 6: NEXT STEPS -->
  <div class="section">
    <div class="section-header">
      <div class="section-number green">6</div>
      <div class="section-title green">Immediate Next Steps (30 Days)</div>
    </div>
    <div class="step-item">
      <div class="step-checkbox"></div>
      <div>
        <div class="step-text">Brief full team on strategic direction &mdash; all-hands by April 10</div>
        <div class="step-owner">Owner: CEO</div>
      </div>
    </div>
    <div class="step-item">
      <div class="step-checkbox"></div>
      <div>
        <div class="step-text">Begin Shield wind-down analysis &mdash; customer migration plan draft by April 15</div>
        <div class="step-owner">Owner: VP Product</div>
      </div>
    </div>
    <div class="step-item">
      <div class="step-checkbox"></div>
      <div>
        <div class="step-text">Engage Whole Foods broker/consultant for retail compliance readiness &mdash; by April 20</div>
        <div class="step-owner">Owner: VP Operations</div>
      </div>
    </div>
    <div class="step-item">
      <div class="step-checkbox"></div>
      <div>
        <div class="step-text">Initiate Whole Foods partnership discussions &mdash; request terms sheet by April 30</div>
        <div class="step-owner">Owner: VP Operations</div>
      </div>
    </div>
    <div class="step-item">
      <div class="step-checkbox"></div>
      <div>
        <div class="step-text">Post wholesale ops job descriptions &mdash; target 2 hires by June 1</div>
        <div class="step-owner">Owner: COO</div>
      </div>
    </div>
    <div class="step-item">
      <div class="step-checkbox"></div>
      <div>
        <div class="step-text">Set up trigger-point dashboard &mdash; CAC, wholesale margin, and revenue vs plan tracked weekly</div>
        <div class="step-owner">Owner: CFO</div>
      </div>
    </div>
  </div>

</div>
</body>
</html>
```

- [ ] **Step 2: Verify the file opens in a browser**

```bash
open tools/executive_strategy_summary.html
```

Expected: A polished scrolling document with green hero header, 6 numbered sections, KPI cards, comparison table, risk rows, contingency cards, and next-steps checklist. Should look like a professional strategy document, not a web app.

- [ ] **Step 3: Commit**

```bash
git add tools/executive_strategy_summary.html
git commit -m "feat: add executive strategy summary HTML presentation"
```

---

## Task 2: Create the Markdown Executive Strategy Summary

**Files:**
- Create: `output/executive_strategy_summary.md`

This task creates the markdown version with identical content.

- [ ] **Step 1: Create the output directory and markdown file**

```bash
mkdir -p output
```

Create `output/executive_strategy_summary.md`:

```markdown
---
title: "Verdana FY2027 Executive Strategy Summary"
version: 1.0
date: 2026-04-06
status: confidential
---

# Verdana FY2027 Executive Strategy Summary

*Prepared April 2026 · Confidential*

---

## 1. Executive Overview

Verdana is an $8M annual revenue direct-to-consumer adaptogen supplement company with 60 employees. Built on a foundation of clinical transparency — publishing dosages, sourcing, and third-party test results that most brands hide — Verdana has earned the trust of health-conscious professionals who are skeptical of wellness hype.

However, the company has hit a growth plateau. Revenue has been flat for two consecutive quarters. Customer acquisition cost has risen 41% year-over-year to $58, driven by increasing Meta CPMs, iOS privacy changes, and podcast ad saturation. Monthly new customers have declined from 1,800 to 1,400 over the past six months, and the LTV:CAC ratio has dropped from 5.2:1 to 3.8:1.

The leadership team faces three interconnected strategic decisions: whether to expand into wholesale retail (Whole Foods and Target have both expressed interest), how to handle the underperforming Shield SKU (volume down 18% YoY, highest return rate), and whether to launch new products from the R&D pipeline (Metabolize and Glow). The company cannot pursue all options simultaneously — this document recommends a path and projects its impact.

| Metric | Current |
|---|---|
| Revenue | $8.0M |
| Gross Margin | 76.4% |
| CAC | $58 (up 41% YoY) |
| Team | 60 people |

---

## 2. Recommended Strategic Direction

> **Selective Expansion: Wholesale + Cut Shield**
>
> Enter Whole Foods regional (85 stores, Pacific Northwest and Northern California) while discontinuing the underperforming Shield SKU. Reallocate Shield resources — 60% to marketing for CAC reduction, 40% to margin improvement. Hold new product launches (Metabolize, Glow) for Year 2, contingent on wholesale success.

### Why This Path

- **Revenue Unlock:** Wholesale adds $2.1M in Year 3 revenue while DTC optimization continues to compound. Two growth engines instead of one.
- **Margin Defense:** Cutting Shield reclaims 1.2% blended margin, partially offsetting wholesale margin drag. Net gross profit increases despite lower margin rate.
- **Manageable Risk:** Two strategic moves, not three. Keeps execution bandwidth focused for a 60-person team. Medium risk profile with clear contingencies.

### Supporting Evidence

**Scenario Modeler:** The Wholesale + Cut Shield combination projects $12.4M Year 3 revenue versus $9.8M baseline — a $2.6M uplift. Adding new products would push to a high-risk profile for only $2.2M additional upside, an unfavorable risk-to-reward ratio for a company of Verdana's scale.

**Market Sizing:** Whole Foods at 85 stores with 24 units per store per month at 50% wholesale discount yields meaningful revenue with a manageable 6-month ramp. Target national is deferred until Whole Foods proves the retail model. DTC cannibalization is modeled conservatively at 10%.

**OKR Alignment:** This path maps directly to the Base Case OKR framework: reduce CAC from $58 to $45, grow subscription rate from 34% to 40%, and rationalize the product portfolio. Shield discontinuation frees R&D and marketing bandwidth for the objectives that matter most.

**Competitive Positioning:** Verdana's transparency score (95/100) is its strongest moat. Whole Foods' premium health aisle reinforces clinical positioning rather than diluting it — unlike Target, which carries brand dilution risk. The closest competitive threat is Ritual (85/100 transparency, $100M+ scale). Establishing retail presence now builds a distribution advantage before Ritual potentially enters adaptogens.

---

## 3. 3-Year Financial Projections

| Metric | Baseline (Stay the Course) | Recommended (WS + Cut Shield) | Delta |
|---|---|---|---|
| Y1 Revenue | $8.4M | $9.1M | +$700K |
| Y2 Revenue | $9.1M | $10.8M | +$1.7M |
| Y3 Revenue | $9.8M | $12.4M | +$2.6M |
| Y3 Gross Margin | 76.4% | 68.2% | -8.2% |
| Y3 Gross Profit | $7.5M | $8.5M | +$1.0M |
| 3Y Cumulative Investment | $0 | $420K | +$420K |
| Y3 Headcount | 60 | 64 | +4 |

**Net impact:** $2.6M additional Year 3 revenue at the cost of 8.2% margin compression and $420K cumulative investment. Year 3 gross profit reaches $8.5M under the recommended path versus $7.5M at baseline — a $1.0M improvement in absolute profit despite the lower margin rate. The investment pays back within Year 1 wholesale revenue.

---

## 4. Key Risks & Mitigations

| Risk | Description | Mitigation |
|---|---|---|
| **Brand Dilution** | Retail shelf presence may undermine premium DTC positioning and the clinical trust Verdana has built. | Start regional (Whole Foods only), monitor brand sentiment quarterly, maintain premium in-store presentation. |
| **Margin Compression** | Wholesale at ~38% gross versus 76% DTC drags the blended margin by 8.2 percentage points. | Track gross profit dollars, not margin %. Shield savings offset ~1.2%. Negotiate toward 45% discount at volume. |
| **Ops Complexity** | EDI integration, retail compliance, and chargeback management are entirely new capabilities for the team. | Hire wholesale ops team before launch. Budget $150K for systems buildout. 6-month ramp protects against early stumbles. |
| **DTC Cannibalization** | Some existing DTC customers may shift to retail purchases at lower margin. | Model 10% cannibalization (conservative). Monitor DTC metrics weekly post-launch. Geographic overlap analysis. |
| **Customer Disruption** | Shield subscribers need a migration path. Some will churn entirely rather than switch products. | Proactive communication plan. Offer Focus or Calm as replacement with transition discount. Target < 5% subscriber loss. |

---

## 5. What If We're Wrong? Contingency Paths

### Path B — Escalate (All Three Moves)

If wholesale exceeds expectations, add the Metabolize launch to the plan. This raises the Year 3 ceiling to $14.6M but pushes to a high-risk profile with $720K investment and +7 headcount. The logic: prove wholesale ops capability first, then layer on product launch complexity from a position of strength.

**Trigger:** Wholesale gross margin > 42% by Q2 Year 1

### Path C — Retreat (DTC Only)

If wholesale underperforms, pause the expansion and redirect investment into DTC optimization, subscription growth, and loyalty program development. Year 3 floor: $9.8M revenue, low risk. This is not failure — it's the original business model, optimized. The DTC channel still has room to grow through CAC reduction and retention improvement.

**Trigger:** Wholesale revenue < 30% of projection by Q2 Year 1

---

## 6. Immediate Next Steps (30 Days)

- [ ] Brief full team on strategic direction — all-hands by April 10 *(Owner: CEO)*
- [ ] Begin Shield wind-down analysis — customer migration plan draft by April 15 *(Owner: VP Product)*
- [ ] Engage Whole Foods broker/consultant for retail compliance readiness — by April 20 *(Owner: VP Operations)*
- [ ] Initiate Whole Foods partnership discussions — request terms sheet by April 30 *(Owner: VP Operations)*
- [ ] Post wholesale ops job descriptions — target 2 hires by June 1 *(Owner: COO)*
- [ ] Set up trigger-point dashboard — CAC, wholesale margin, and revenue vs plan tracked weekly *(Owner: CFO)*
```

- [ ] **Step 2: Commit**

```bash
git add output/executive_strategy_summary.md
git commit -m "feat: add executive strategy summary markdown document"
```

---

## Task 3: Process Log and Tutorial

**Files:**
- Modify: `docs/process_log.md`
- Create: `tutorials/05_executive_strategy_summary.md`

- [ ] **Step 1: Update process log**

Prepend a new entry to `docs/process_log.md` (newest first, before the "## 2026-04-06 — Competitive Positioning Map" entry):

```markdown
## 2026-04-06 — Executive Strategy Summary

**Prompt:** Build a tool that reads all the Verdana data — the brand definition, OKR goals, market sizing results, scenario model outputs, and competitive positioning — and generates a polished executive strategy summary. Include an executive overview, recommended strategic direction with rationale, 3-year financial projections, key risks, and immediate next steps. Output as both a formatted HTML presentation and a markdown document.

**What was built:** A synthesized executive strategy document recommending "Selective Expansion: Wholesale + Cut Shield" with supporting evidence from all four planning tools. Output as both a styled HTML scrolling narrative (`tools/executive_strategy_summary.html`) and a markdown document (`output/executive_strategy_summary.md`).

**Key decisions:**
- Recommended a specific path (Wholesale + Cut Shield) with contingency alternatives, rather than presenting options neutrally — executives want a thesis to react to
- Scrolling narrative format rather than slide deck — better for async reading, email distribution, and printing
- Two-column financial comparison (baseline vs recommended) rather than three — the contrast between "do nothing" and "recommended" is the most persuasive framing
- Included trigger points for contingency paths (Path B: escalate, Path C: retreat) to show the team has thought through failure modes
- Static content baked from analysis, not dynamically computed — this is a synthesis document, not another calculator

**Files created/modified:**
- `tools/executive_strategy_summary.html` (created)
- `output/executive_strategy_summary.md` (created)
- `docs/superpowers/specs/2026-04-06-executive-strategy-summary-design.md` (created)
- `docs/superpowers/plans/2026-04-06-executive-strategy-summary.md` (created)
- `docs/process_log.md` (modified)
- `tutorials/05_executive_strategy_summary.md` (created)
```

- [ ] **Step 2: Create tutorial**

Create `tutorials/05_executive_strategy_summary.md`:

```markdown
---
title: "Tutorial: Building the Verdana Executive Strategy Summary"
tool: Executive Strategy Summary
sequence: 5
created: 2026-04-06
---

# Tutorial: Building the Verdana Executive Strategy Summary

## What We Built

A polished executive strategy document that synthesizes all Verdana planning data into a single coherent recommendation — output as both a styled HTML scrolling narrative and a markdown document.

## The Prompt

> Build a tool that reads all the Verdana data — the brand definition, OKR goals, market sizing results, scenario model outputs, and competitive positioning — and generates a polished executive strategy summary. Include an executive overview, recommended strategic direction with rationale, 3-year financial projections, key risks, and immediate next steps. Output as both a formatted HTML presentation and a markdown document.

## Key Design Decisions

### 1. Recommend, Don't Just Present

Executives want a thesis they can react to, not a menu of options. We led with a clear recommendation (Wholesale + Cut Shield) backed by evidence from each planning tool, then added contingency paths with trigger points for when to pivot.

### 2. Scrolling Narrative Over Slides

A strategy summary is a reading document, not a presentation deck. The scrolling format controls pacing (context, then recommendation, then evidence, then risks), works in email, and prints cleanly.

### 3. Baseline vs Recommended Comparison

Two columns, not three. The contrast between "do nothing" ($9.8M Y3) and "recommended path" ($12.4M Y3) is the most powerful argument for action. The aggressive alternative is covered in the contingencies section.

### 4. Static Synthesis, Not Dynamic

Unlike the scenario modeler or market sizing calculator, this document has baked-in content. It's the output of the planning process, not another input. The analytical tools do the exploring; this document does the deciding.

## How to Replicate

1. Build the analytical tools first (scenario modeler, market sizing, OKR planner, competitive positioning)
2. Run each tool to identify the strongest strategic path
3. Write the recommendation as a thesis with evidence sourced from each tool
4. Add financial projections comparing baseline vs recommended
5. Include risks with mitigations and contingency paths with quantified trigger points
6. End with concrete next steps — owners, dates, actions

## Output

- `tools/executive_strategy_summary.html` — open in any browser
- `output/executive_strategy_summary.md` — for distribution and version control
```

- [ ] **Step 3: Commit**

```bash
git add docs/process_log.md tutorials/05_executive_strategy_summary.md
git commit -m "docs: add process log and tutorial for executive strategy summary"
```
